MAM
AURA icon

Martingale Asset Management’s Aura Biosciences AURA Stock Holding History

Martingale Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Buy
+71,258
New +$510K 0.01% 659
2023
Q4 		– Sell
-24,665
Closed -$221K – 789
2023
Q3 		$221K Hold
24,665
– – ﹤0.01% 732
2023
Q2 		$305K Buy
24,665
+4,311
+21% +$46.1K 0.01% 696
2023
Q1 		$189K Buy
+20,354
New +$211K ﹤0.01% 786

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Martingale Asset Management's AURA Position: Q2 2026 in Review

Martingale Asset Management opened a new position in Aura Biosciences (AURA) in Q2 2026: 71,258 shares worth $506K. The stake represents 0.01% of the portfolio and ranks #659 among its holdings. This is a return to the name: Martingale Asset Management previously reported a position in AURA as recently as Q3 2023.

Martingale Asset Management first reported a position in AURA in Q1 2023 and has held it in 4 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Martingale Asset Management held 71,258 shares of Aura Biosciences worth $506K as of Q2 2026.
  • Aura Biosciences was a new Martingale Asset Management position in Q2 2026.
  • Aura Biosciences made up 0.01% of Martingale Asset Management's portfolio in Q2 2026, its #659 holding.
  • Martingale Asset Management first reported a position in Aura Biosciences in Q1 2023 and has held it in 4 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.